Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | nuclear factor, erythroid 2-like 2 | Starlite/ChEMBL | No references |
Homo sapiens | thyroid hormone receptor, beta | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Brugia malayi | photoreceptor-specific nuclear receptor | thyroid hormone receptor, beta | 461 aa | 414 aa | 24.6 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | isocitrate dehydrogenase 2 (NADP+) | 0.0034 | 0.0176 | 0.0176 |
Entamoeba histolytica | hypothetical protein | 0.0043 | 0.0915 | 0.5 |
Brugia malayi | RNA binding protein | 0.0063 | 0.2369 | 0.466 |
Entamoeba histolytica | hypothetical protein | 0.0043 | 0.0915 | 0.5 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0099 | 0.5082 | 1 |
Echinococcus multilocularis | isocitrate dehydrogenase | 0.0034 | 0.0176 | 0.0176 |
Brugia malayi | isocitrate dehydrogenase | 0.0034 | 0.0176 | 0.0346 |
Loa Loa (eye worm) | isocitrate dehydrogenase | 0.0034 | 0.0176 | 0.0346 |
Brugia malayi | hypothetical protein | 0.0043 | 0.0915 | 0.1801 |
Echinococcus multilocularis | NADP dependent isocitrate dehydrogenase | 0.0034 | 0.0176 | 0.0176 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0099 | 0.5082 | 1 |
Schistosoma mansoni | thyroid hormone receptor | 0.0164 | 1 | 1 |
Loa Loa (eye worm) | TAR-binding protein | 0.0063 | 0.2369 | 0.466 |
Entamoeba histolytica | hypothetical protein | 0.0043 | 0.0915 | 0.5 |
Trypanosoma cruzi | isocitrate dehydrogenase [NADP], mitochondrial precursor, putative | 0.0034 | 0.0176 | 0.5 |
Echinococcus granulosus | tar DNA binding protein | 0.0063 | 0.2369 | 0.2608 |
Schistosoma mansoni | tar DNA-binding protein | 0.0063 | 0.2369 | 0.2369 |
Plasmodium falciparum | isocitrate dehydrogenase [NADP], mitochondrial | 0.0034 | 0.0176 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0068 | 0.273 | 0.5371 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription | 0.0043 | 0.0915 | 0.0915 |
Schistosoma mansoni | tar DNA-binding protein | 0.0063 | 0.2369 | 0.2369 |
Schistosoma mansoni | tar DNA-binding protein | 0.0063 | 0.2369 | 0.2369 |
Trypanosoma brucei | isocitrate dehydrogenase [NADP], mitochondrial precursor, putative | 0.0034 | 0.0176 | 0.5 |
Brugia malayi | TAR-binding protein | 0.0063 | 0.2369 | 0.466 |
Schistosoma mansoni | transcription factor LCR-F1 | 0.0043 | 0.0915 | 0.0915 |
Toxoplasma gondii | isocitrate dehydrogenase | 0.0034 | 0.0176 | 0.5 |
Trypanosoma cruzi | isocitrate dehydrogenase, putative | 0.0034 | 0.0176 | 0.5 |
Loa Loa (eye worm) | RNA binding protein | 0.0063 | 0.2369 | 0.466 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0099 | 0.5082 | 1 |
Mycobacterium tuberculosis | Probable isocitrate dehydrogenase [NADP] Icd1 (oxalosuccinate decarboxylase) (IDH) (NADP+-specific ICDH) (IDP) | 0.0034 | 0.0176 | 0.5 |
Entamoeba histolytica | hypothetical protein | 0.0043 | 0.0915 | 0.5 |
Echinococcus multilocularis | NADP dependent isocitrate dehydrogenase | 0.0034 | 0.0176 | 0.0176 |
Echinococcus granulosus | Mitotic checkpoint protein PRCC C terminal | 0.0152 | 0.9082 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0063 | 0.2369 | 0.2369 |
Schistosoma mansoni | tar DNA-binding protein | 0.0063 | 0.2369 | 0.2369 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0068 | 0.273 | 0.5371 |
Schistosoma mansoni | hypothetical protein | 0.0068 | 0.273 | 0.273 |
Schistosoma mansoni | thyroid hormone receptor | 0.0164 | 1 | 1 |
Echinococcus multilocularis | Mitotic checkpoint protein PRCC, C terminal | 0.0152 | 0.9082 | 0.9082 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0063 | 0.2369 | 0.466 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0063 | 0.2369 | 0.466 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription | 0.0043 | 0.0915 | 0.1008 |
Schistosoma mansoni | hypothetical protein | 0.0043 | 0.0915 | 0.0915 |
Schistosoma mansoni | hypothetical protein | 0.0152 | 0.9082 | 0.9082 |
Toxoplasma gondii | isocitrate dehydrogenase | 0.0034 | 0.0176 | 0.5 |
Trypanosoma brucei | isocitrate dehydrogenase, putative | 0.0034 | 0.0176 | 0.5 |
Brugia malayi | Isocitrate dehydrogenase | 0.0034 | 0.0176 | 0.0346 |
Echinococcus multilocularis | NADP dependent isocitrate dehydrogenase | 0.0034 | 0.0176 | 0.0176 |
Loa Loa (eye worm) | hypothetical protein | 0.0099 | 0.5082 | 1 |
Plasmodium vivax | isocitrate dehydrogenase [NADP], mitochondrial, putative | 0.0034 | 0.0176 | 0.5 |
Echinococcus multilocularis | tar DNA binding protein | 0.0063 | 0.2369 | 0.2369 |
Echinococcus granulosus | NADP dependent isocitrate dehydrogenase | 0.0034 | 0.0176 | 0.0193 |
Schistosoma mansoni | NADP-specific isocitrate dehydrogenase | 0.0034 | 0.0176 | 0.0176 |
Leishmania major | isocitrate dehydrogenase [NADP], mitochondrial precursor, putative | 0.0034 | 0.0176 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | = 0.0089 um | PUBCHEM_BIOASSAY: Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 14.581 uM | PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648] | ChEMBL. | No reference |
Potency (functional) | 35.4813 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b: Cytotox Counterscreen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588855, AID588860] | ChEMBL. | No reference |
Potency (functional) | 50.1187 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of mutant isocitrate dehydrogenase 1 (IDH1): qHTS. (Class of assay: confirmatory) | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.